𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rituximab-induced interstitial lung disease in a patient with immune thrombocytopenia purpura

✍ Scribed by N. Child; M. O'Carroll; L. Berkahn


Book ID
115183374
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
308 KB
Volume
42
Category
Article
ISSN
1444-0903

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Percutaneous coronary intervention in a
✍ George A. Stouffer; Jana Hirmerova; Stephan Moll; Bryon Rubery; Mark Napoli; E. πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 142 KB πŸ‘ 2 views

## Abstract The appropriate regimen of platelet inhibitors that should be used in patients with immune thrombocytopenia purpura (ITP; formerly called idiopathic thrombocytopenic purpura) who are undergoing percutaneous coronary intervention is unclear. We report the case of a patient with ITP who u

Rituximab-induced acute thrombocytopenia
✍ GΓΌlsΓΌm Emel Pamuk; Salim Donmez; Burhan Turgut; Muzaffer Demir; Ozden Vural πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 137 KB πŸ‘ 2 views

## HTLV-1-Related Lymphoma in Hong Kong Chinese To the Editor: Human T-cell lymphotropic virus type 1 (HTLV-1) is an endemic infection in Southwest Japan and northern Taiwan [1] with carrier rates from 6% to 37% [2] and a 2.5% lifetime risk of adult T-cell lymphoma leukemia (ATLL). It accounts for